Supplementary Data from TIM-3 Dictates Functional Orientation of the Immune Infiltrate in Ovarian Cancer Article Swipe

View

Jitka Fučíková , Jana Raková , Michal Hensler , Lenka Kašíková , Lucie Belicova , Kamila Hladíková , Iva Truxová , Petr Škapa , Ján Laco , Ladislav Pecen , Ivan Práznovec , Michael J. Halaška , Tomáš Brtnický , Roman Kodet , Anna Fialová , Joséphine Pineau , Alain Gey , Éric Tartour , Aleš Ryška , Lorenzo Galluzzi , Radek Špíšek ·

YOU? · · 2023 · Open Access · · DOI: https://doi.org/10.1158/1078-0432.22472085.v1

Supplemental material, figures and tables Supplemental Figure 1. Experimental design of the study. Supplemental Figure 2. Tumor infiltration by CD8+ T cells, CD20+ B cells and DC-LAMP+ cells correlate with prolonged survival in patients with HGSC. Supplemental Figure 3. Representative images of PD-L1 (scale bar = 100 μm) and PD-1 (Scale bar = 50 μm ) immunostaining. Supplemental Figure 4. Representative images of CTLA4 (scale bar = 50 μm) and LAG-3 (Scale bar = 50 μm ) immunostaining. Supplemental Figure 5. PD-L1 levels and infiltration by PD-1+, CTLA4+ and LAG-3+ cells were heterogeneous across samples but did not differ based on site of assessment. Supplemental Figure 6. PD-L1, PD-1 and CTLA4 expression on freshly isolated CD8+ T cells after exposure to recombinant IFNγ. Supplemental Figure 7. Representative images of 3 different samples of PD-1Lo/CD8Lo, PD-1Hi/CD8Hi, PD-1Lo/CD20/DC-LAMPLo and PD-1Hi/CD20/DC-LAMPHi immunostaining. Scale bar = 100 μm. Supplemental Figure 8: The combined prognostic impact of CD8+ T cells and PD-1+, LAG-3+ and CTLA4+ cells in HGSC. Supplemental table 1. Main clinical and biological characteristics of 20 HGSC patients in which the freshly resected tumors were analyzed using flow cytometry (Study group 2). Supplemental Table 2. The list of antibodies used for IHC staining. Supplemental table 3. The list of antibodies used for flow cytometry. Supplemental Table 4. The list of genes used by MCP counter for identification of distinct cell populations. Supplemental Table 5. The list of antibodies used for in situ immunofluorescence staining. Supplemental Table 6. Genes differentially represented in PD-1Hi vs PD-1Lo HGSCs. Supplemental Table 7. Genes differentially represented in TIM-3Hi vs TIM-3Lo HGSCs. Supplemental Table 8. Results of biostatistic analysis comparing expression of PD-L1 and density of PD-1+, LAG-3+, CTLA4+, CD8+, DC-LAMP+ and CD20+ cells in tumor microenvironment of ImmuneHi/TIM-3Hi vs ImmuneHi/TIM-3Lo and ImmuneLo/TIM-3Hi vs ImmuneLo/TIM-3Lo.

Related Topics

Concepts

Immunostaining CD20 CD8 Flow cytometry Antibody Immunohistochemistry Medicine Immune system Biology Pathology Immunology

Metadata

Type: preprint
Language: en
Landing Page: https://doi.org/10.1158/1078-0432.22472085.v1
OA Status: gold
Related Works: 10
OpenAlex ID: https://openalex.org/W4361935272

All OpenAlex metadata

Raw OpenAlex JSON

OpenAlex ID: https://openalex.org/W4361935272

Canonical identifier for this work in OpenAlex
DOI: https://doi.org/10.1158/1078-0432.22472085.v1

Digital Object Identifier
Title: Supplementary Data from TIM-3 Dictates Functional Orientation of the Immune Infiltrate in Ovarian Cancer

Work title
Type: preprint

OpenAlex work type
Language: en

Primary language
Publication year: 2023

Year of publication
Publication date: 2023-03-31

Full publication date if available
Authors: Jitka Fučíková, Jana Raková, Michal Hensler, Lenka Kašíková, Lucie Belicova, Kamila Hladíková, Iva Truxová, Petr Škapa, Ján Laco, Ladislav Pecen, Ivan Práznovec, Michael J. Halaška, Tomáš Brtnický, Roman Kodet, Anna Fialová, Joséphine Pineau, Alain Gey, Éric Tartour, Aleš Ryška, Lorenzo Galluzzi, Radek Špíšek

List of authors in order
Landing page: https://doi.org/10.1158/1078-0432.22472085.v1

Publisher landing page
Open access: Yes

Whether a free full text is available
OA status: gold

Open access status per OpenAlex
OA URL: https://doi.org/10.1158/1078-0432.22472085.v1

Direct OA link when available
Concepts: Immunostaining, CD20, CD8, Flow cytometry, Antibody, Immunohistochemistry, Medicine, Immune system, Biology, Pathology, Immunology

Top concepts (fields/topics) attached by OpenAlex
Cited by: 0

Total citation count in OpenAlex
Related works (count): 10

Other works algorithmically related by OpenAlex

Full payload

id	https://openalex.org/W4361935272
doi	https://doi.org/10.1158/1078-0432.22472085.v1
ids.doi	https://doi.org/10.1158/1078-0432.22472085.v1
ids.openalex	https://openalex.org/W4361935272
fwci	0.0
type	preprint
title	Supplementary Data from TIM-3 Dictates Functional Orientation of the Immune Infiltrate in Ovarian Cancer
biblio.issue
biblio.volume
biblio.last_page
biblio.first_page
topics[0].id	https://openalex.org/T10158
topics[0].field.id	https://openalex.org/fields/27
topics[0].field.display_name	Medicine
topics[0].score	0.996399998664856
topics[0].domain.id	https://openalex.org/domains/4
topics[0].domain.display_name	Health Sciences
topics[0].subfield.id	https://openalex.org/subfields/2730
topics[0].subfield.display_name	Oncology
topics[0].display_name	Cancer Immunotherapy and Biomarkers
topics[1].id	https://openalex.org/T11313
topics[1].field.id	https://openalex.org/fields/24
topics[1].field.display_name	Immunology and Microbiology
topics[1].score	0.9801999926567078
topics[1].domain.id	https://openalex.org/domains/1
topics[1].domain.display_name	Life Sciences
topics[1].subfield.id	https://openalex.org/subfields/2403
topics[1].subfield.display_name	Immunology
topics[1].display_name	Immune cells in cancer
topics[2].id	https://openalex.org/T10550
topics[2].field.id	https://openalex.org/fields/27
topics[2].field.display_name	Medicine
topics[2].score	0.9771000146865845
topics[2].domain.id	https://openalex.org/domains/4
topics[2].domain.display_name	Health Sciences
topics[2].subfield.id	https://openalex.org/subfields/2743
topics[2].subfield.display_name	Reproductive Medicine
topics[2].display_name	Ovarian cancer diagnosis and treatment
is_xpac	False
apc_list
apc_paid
concepts[0].id	https://openalex.org/C4224716
concepts[0].level	3
concepts[0].score	0.7880165576934814
concepts[0].wikidata	https://www.wikidata.org/wiki/Q10859258
concepts[0].display_name	Immunostaining
concepts[1].id	https://openalex.org/C18031839
concepts[1].level	3
concepts[1].score	0.6172467470169067
concepts[1].wikidata	https://www.wikidata.org/wiki/Q5009796
concepts[1].display_name	CD20
concepts[2].id	https://openalex.org/C167672396
concepts[2].level	3
concepts[2].score	0.5677912831306458
concepts[2].wikidata	https://www.wikidata.org/wiki/Q417800
concepts[2].display_name	CD8
concepts[3].id	https://openalex.org/C553184892
concepts[3].level	2
concepts[3].score	0.5556386709213257
concepts[3].wikidata	https://www.wikidata.org/wiki/Q1141429
concepts[3].display_name	Flow cytometry
concepts[4].id	https://openalex.org/C159654299
concepts[4].level	2
concepts[4].score	0.49932312965393066
concepts[4].wikidata	https://www.wikidata.org/wiki/Q79460
concepts[4].display_name	Antibody
concepts[5].id	https://openalex.org/C204232928
concepts[5].level	2
concepts[5].score	0.4500541687011719
concepts[5].wikidata	https://www.wikidata.org/wiki/Q899285
concepts[5].display_name	Immunohistochemistry
concepts[6].id	https://openalex.org/C71924100
concepts[6].level	0
concepts[6].score	0.380908727645874
concepts[6].wikidata	https://www.wikidata.org/wiki/Q11190
concepts[6].display_name	Medicine
concepts[7].id	https://openalex.org/C8891405
concepts[7].level	2
concepts[7].score	0.3786298334598541
concepts[7].wikidata	https://www.wikidata.org/wiki/Q1059
concepts[7].display_name	Immune system
concepts[8].id	https://openalex.org/C86803240
concepts[8].level	0
concepts[8].score	0.3626371920108795
concepts[8].wikidata	https://www.wikidata.org/wiki/Q420
concepts[8].display_name	Biology
concepts[9].id	https://openalex.org/C142724271
concepts[9].level	1
concepts[9].score	0.3597322106361389
concepts[9].wikidata	https://www.wikidata.org/wiki/Q7208
concepts[9].display_name	Pathology
concepts[10].id	https://openalex.org/C203014093
concepts[10].level	1
concepts[10].score	0.3364051580429077
concepts[10].wikidata	https://www.wikidata.org/wiki/Q101929
concepts[10].display_name	Immunology
keywords[0].id	https://openalex.org/keywords/immunostaining
keywords[0].score	0.7880165576934814
keywords[0].display_name	Immunostaining
keywords[1].id	https://openalex.org/keywords/cd20
keywords[1].score	0.6172467470169067
keywords[1].display_name	CD20
keywords[2].id	https://openalex.org/keywords/cd8
keywords[2].score	0.5677912831306458
keywords[2].display_name	CD8
keywords[3].id	https://openalex.org/keywords/flow-cytometry
keywords[3].score	0.5556386709213257
keywords[3].display_name	Flow cytometry
keywords[4].id	https://openalex.org/keywords/antibody
keywords[4].score	0.49932312965393066
keywords[4].display_name	Antibody
keywords[5].id	https://openalex.org/keywords/immunohistochemistry
keywords[5].score	0.4500541687011719
keywords[5].display_name	Immunohistochemistry
keywords[6].id	https://openalex.org/keywords/medicine
keywords[6].score	0.380908727645874
keywords[6].display_name	Medicine
keywords[7].id	https://openalex.org/keywords/immune-system
keywords[7].score	0.3786298334598541
keywords[7].display_name	Immune system
keywords[8].id	https://openalex.org/keywords/biology
keywords[8].score	0.3626371920108795
keywords[8].display_name	Biology
keywords[9].id	https://openalex.org/keywords/pathology
keywords[9].score	0.3597322106361389
keywords[9].display_name	Pathology
keywords[10].id	https://openalex.org/keywords/immunology
keywords[10].score	0.3364051580429077
keywords[10].display_name	Immunology
language	en
locations[0].id	doi:10.1158/1078-0432.22472085.v1
locations[0].is_oa	True
locations[0].source
locations[0].license	cc-by
locations[0].pdf_url
locations[0].version	acceptedVersion
locations[0].raw_type	posted-content
locations[0].license_id	https://openalex.org/licenses/cc-by
locations[0].is_accepted	True
locations[0].is_published	False
locations[0].raw_source_name
locations[0].landing_page_url	https://doi.org/10.1158/1078-0432.22472085.v1
locations[1].id	pmh:oai:figshare.com:article/22472085
locations[1].is_oa	True
locations[1].source.id	https://openalex.org/S4306400572
locations[1].source.issn
locations[1].source.type	repository
locations[1].source.is_oa	False
locations[1].source.issn_l
locations[1].source.is_core	False
locations[1].source.is_in_doaj	False
locations[1].source.display_name	OPAL (Open@LaTrobe) (La Trobe University)
locations[1].source.host_organization	https://openalex.org/I196829312
locations[1].source.host_organization_name	La Trobe University
locations[1].source.host_organization_lineage	https://openalex.org/I196829312
locations[1].license	cc-by
locations[1].pdf_url
locations[1].version	submittedVersion
locations[1].raw_type	Text
locations[1].license_id	https://openalex.org/licenses/cc-by
locations[1].is_accepted	False
locations[1].is_published	False
locations[1].raw_source_name
locations[1].landing_page_url	https://figshare.com/articles/journal_contribution/Supplementary_Data_from_TIM-3_Dictates_Functional_Orientation_of_the_Immune_Infiltrate_in_Ovarian_Cancer/22472085
indexed_in	crossref
authorships[0].author.id	https://openalex.org/A5049805426
authorships[0].author.orcid	https://orcid.org/0000-0002-8423-479X
authorships[0].author.display_name	Jitka Fučíková
authorships[0].author_position	first
authorships[0].raw_author_name	Jitka Fucikova
authorships[0].is_corresponding	False
authorships[1].author.id	https://openalex.org/A5112838066
authorships[1].author.orcid
authorships[1].author.display_name	Jana Raková
authorships[1].author_position	middle
authorships[1].raw_author_name	Jana Rakova
authorships[1].is_corresponding	False
authorships[2].author.id	https://openalex.org/A5090378329
authorships[2].author.orcid	https://orcid.org/0000-0002-8767-0722
authorships[2].author.display_name	Michal Hensler
authorships[2].author_position	middle
authorships[2].raw_author_name	Michal Hensler
authorships[2].is_corresponding	False
authorships[3].author.id	https://openalex.org/A5004954459
authorships[3].author.orcid	https://orcid.org/0000-0002-4604-4821
authorships[3].author.display_name	Lenka Kašíková
authorships[3].author_position	middle
authorships[3].raw_author_name	Lenka Kasikova
authorships[3].is_corresponding	False
authorships[4].author.id	https://openalex.org/A5002764845
authorships[4].author.orcid
authorships[4].author.display_name	Lucie Belicova
authorships[4].author_position	middle
authorships[4].raw_author_name	Lucie Belicova
authorships[4].is_corresponding	False
authorships[5].author.id	https://openalex.org/A5011396229
authorships[5].author.orcid
authorships[5].author.display_name	Kamila Hladíková
authorships[5].author_position	middle
authorships[5].raw_author_name	Kamila Hladikova
authorships[5].is_corresponding	False
authorships[6].author.id	https://openalex.org/A5026488935
authorships[6].author.orcid	https://orcid.org/0000-0001-6912-7112
authorships[6].author.display_name	Iva Truxová
authorships[6].author_position	middle
authorships[6].raw_author_name	Iva Truxova
authorships[6].is_corresponding	False
authorships[7].author.id	https://openalex.org/A5020483926
authorships[7].author.orcid	https://orcid.org/0000-0002-7722-3718
authorships[7].author.display_name	Petr Škapa
authorships[7].author_position	middle
authorships[7].raw_author_name	Petr Skapa
authorships[7].is_corresponding	False
authorships[8].author.id	https://openalex.org/A5023424528
authorships[8].author.orcid	https://orcid.org/0000-0002-9602-7501
authorships[8].author.display_name	Ján Laco
authorships[8].author_position	middle
authorships[8].raw_author_name	Jan Laco
authorships[8].is_corresponding	False
authorships[9].author.id	https://openalex.org/A5019501726
authorships[9].author.orcid	https://orcid.org/0000-0001-9827-3178
authorships[9].author.display_name	Ladislav Pecen
authorships[9].author_position	middle
authorships[9].raw_author_name	Ladislav Pecen
authorships[9].is_corresponding	False
authorships[10].author.id	https://openalex.org/A5024096172
authorships[10].author.orcid	https://orcid.org/0000-0003-3878-9417
authorships[10].author.display_name	Ivan Práznovec
authorships[10].author_position	middle
authorships[10].raw_author_name	Ivan Praznovec
authorships[10].is_corresponding	False
authorships[11].author.id	https://openalex.org/A5059654394
authorships[11].author.orcid	https://orcid.org/0000-0001-6055-2569
authorships[11].author.display_name	Michael J. Halaška
authorships[11].author_position	middle
authorships[11].raw_author_name	Michael J. Halaska
authorships[11].is_corresponding	False
authorships[12].author.id	https://openalex.org/A5077647534
authorships[12].author.orcid	https://orcid.org/0000-0002-6204-1903
authorships[12].author.display_name	Tomáš Brtnický
authorships[12].author_position	middle
authorships[12].raw_author_name	Tomas Brtnicky
authorships[12].is_corresponding	False
authorships[13].author.id	https://openalex.org/A5076286235
authorships[13].author.orcid
authorships[13].author.display_name	Roman Kodet
authorships[13].author_position	middle
authorships[13].raw_author_name	Roman Kodet
authorships[13].is_corresponding	False
authorships[14].author.id	https://openalex.org/A5030701957
authorships[14].author.orcid	https://orcid.org/0000-0003-1436-5142
authorships[14].author.display_name	Anna Fialová
authorships[14].author_position	middle
authorships[14].raw_author_name	Anna Fialova
authorships[14].is_corresponding	False
authorships[15].author.id	https://openalex.org/A5021778048
authorships[15].author.orcid	https://orcid.org/0000-0002-7494-5627
authorships[15].author.display_name	Joséphine Pineau
authorships[15].author_position	middle
authorships[15].raw_author_name	Josephine Pineau
authorships[15].is_corresponding	False
authorships[16].author.id	https://openalex.org/A5088494396
authorships[16].author.orcid	https://orcid.org/0000-0002-3821-0674
authorships[16].author.display_name	Alain Gey
authorships[16].author_position	middle
authorships[16].raw_author_name	Alain Gey
authorships[16].is_corresponding	False
authorships[17].author.id	https://openalex.org/A5018415934
authorships[17].author.orcid	https://orcid.org/0000-0002-7323-468X
authorships[17].author.display_name	Éric Tartour
authorships[17].author_position	middle
authorships[17].raw_author_name	Eric Tartour
authorships[17].is_corresponding	False
authorships[18].author.id	https://openalex.org/A5085734287
authorships[18].author.orcid	https://orcid.org/0000-0002-3051-2280
authorships[18].author.display_name	Aleš Ryška
authorships[18].author_position	middle
authorships[18].raw_author_name	Ales Ryska
authorships[18].is_corresponding	False
authorships[19].author.id	https://openalex.org/A5071827163
authorships[19].author.orcid	https://orcid.org/0000-0003-2257-8500
authorships[19].author.display_name	Lorenzo Galluzzi
authorships[19].author_position	middle
authorships[19].raw_author_name	Lorenzo Galluzzi
authorships[19].is_corresponding	False
authorships[20].author.id	https://openalex.org/A5011373942
authorships[20].author.orcid
authorships[20].author.display_name	Radek Špíšek
authorships[20].author_position	last
authorships[20].raw_author_name	Radek Spisek
authorships[20].is_corresponding	False
has_content.pdf	False
has_content.grobid_xml	False
is_paratext	False
open_access.is_oa	True
open_access.oa_url	https://doi.org/10.1158/1078-0432.22472085.v1
open_access.oa_status	gold
open_access.any_repository_has_fulltext	False
created_date	2025-10-10T00:00:00
display_name	Supplementary Data from TIM-3 Dictates Functional Orientation of the Immune Infiltrate in Ovarian Cancer
has_fulltext	False
is_retracted	False
updated_date	2025-11-06T03:46:38.306776
primary_topic.id	https://openalex.org/T10158
primary_topic.field.id	https://openalex.org/fields/27
primary_topic.field.display_name	Medicine
primary_topic.score	0.996399998664856
primary_topic.domain.id	https://openalex.org/domains/4
primary_topic.domain.display_name	Health Sciences
primary_topic.subfield.id	https://openalex.org/subfields/2730
primary_topic.subfield.display_name	Oncology
primary_topic.display_name	Cancer Immunotherapy and Biomarkers
related_works	https://openalex.org/W2512703498, https://openalex.org/W110523806, https://openalex.org/W2347823473, https://openalex.org/W2300147703, https://openalex.org/W1546067550, https://openalex.org/W1979893467, https://openalex.org/W2056351008, https://openalex.org/W31383154, https://openalex.org/W3134667467, https://openalex.org/W1954489675
cited_by_count	0
locations_count	2
best_oa_location.id	doi:10.1158/1078-0432.22472085.v1
best_oa_location.is_oa	True
best_oa_location.source
best_oa_location.license	cc-by
best_oa_location.pdf_url
best_oa_location.version	acceptedVersion
best_oa_location.raw_type	posted-content
best_oa_location.license_id	https://openalex.org/licenses/cc-by
best_oa_location.is_accepted	True
best_oa_location.is_published	False
best_oa_location.raw_source_name
best_oa_location.landing_page_url	https://doi.org/10.1158/1078-0432.22472085.v1
primary_location.id	doi:10.1158/1078-0432.22472085.v1
primary_location.is_oa	True
primary_location.source
primary_location.license	cc-by
primary_location.pdf_url
primary_location.version	acceptedVersion
primary_location.raw_type	posted-content
primary_location.license_id	https://openalex.org/licenses/cc-by
primary_location.is_accepted	True
primary_location.is_published	False
primary_location.raw_source_name
primary_location.landing_page_url	https://doi.org/10.1158/1078-0432.22472085.v1
publication_date	2023-03-31
publication_year	2023
referenced_works_count	0
abstract_inverted_index.)	55, 76
abstract_inverted_index.3	129
abstract_inverted_index.=	45, 52, 66, 73, 141
abstract_inverted_index.B	23
abstract_inverted_index.T	20, 116, 153
abstract_inverted_index.1.	7, 165
abstract_inverted_index.2.	15, 191
abstract_inverted_index.20	172
abstract_inverted_index.3.	38, 202
abstract_inverted_index.4.	59, 213
abstract_inverted_index.5.	80, 230
abstract_inverted_index.50	53, 67, 74
abstract_inverted_index.6.	106, 243
abstract_inverted_index.7.	125, 254
abstract_inverted_index.8.	265
abstract_inverted_index.8:	146
abstract_inverted_index.by	18, 85, 219
abstract_inverted_index.in	32, 161, 175, 237, 247, 258, 285
abstract_inverted_index.of	10, 41, 62, 102, 128, 132, 151, 171, 194, 205, 216, 224, 233, 267, 272, 276, 288
abstract_inverted_index.on	100, 112
abstract_inverted_index.to	120
abstract_inverted_index.vs	249, 260, 290, 294
abstract_inverted_index.100	46, 142
abstract_inverted_index.2).	188
abstract_inverted_index.IHC	198
abstract_inverted_index.MCP	220
abstract_inverted_index.The	147, 192, 203, 214, 231
abstract_inverted_index.and	3, 25, 48, 69, 83, 88, 109, 136, 155, 158, 168, 274, 282, 292
abstract_inverted_index.bar	44, 51, 65, 72, 140
abstract_inverted_index.but	95
abstract_inverted_index.did	96
abstract_inverted_index.for	197, 208, 222, 236
abstract_inverted_index.not	97
abstract_inverted_index.the	11, 177
abstract_inverted_index.μm	54, 75
abstract_inverted_index.CD8+	19, 115, 152
abstract_inverted_index.HGSC	173
abstract_inverted_index.Main	166
abstract_inverted_index.PD-1	49, 108
abstract_inverted_index.cell	226
abstract_inverted_index.flow	184, 209
abstract_inverted_index.list	193, 204, 215, 232
abstract_inverted_index.site	101
abstract_inverted_index.situ	238
abstract_inverted_index.used	196, 207, 218, 235
abstract_inverted_index.were	91, 181
abstract_inverted_index.with	29, 34
abstract_inverted_index.μm)	47, 68
abstract_inverted_index.μm.	143
abstract_inverted_index.CD20+	22, 283
abstract_inverted_index.CD8+,	280
abstract_inverted_index.CTLA4	63, 110
abstract_inverted_index.Genes	244, 255
abstract_inverted_index.HGSC.	35, 162
abstract_inverted_index.LAG-3	70
abstract_inverted_index.PD-L1	42, 81, 273
abstract_inverted_index.Scale	139
abstract_inverted_index.Table	190, 212, 229, 242, 253, 264
abstract_inverted_index.Tumor	16
abstract_inverted_index.after	118
abstract_inverted_index.based	99
abstract_inverted_index.cells	24, 27, 90, 117, 154, 160, 284
abstract_inverted_index.genes	217
abstract_inverted_index.group	187
abstract_inverted_index.table	164, 201
abstract_inverted_index.tumor	286
abstract_inverted_index.using	183
abstract_inverted_index.which	176
abstract_inverted_index.(Scale	50, 71
abstract_inverted_index.(Study	186
abstract_inverted_index.(scale	43, 64
abstract_inverted_index.CTLA4+	87, 159
abstract_inverted_index.Figure	6, 14, 37, 58, 79, 105, 124, 145
abstract_inverted_index.HGSCs.	251, 262
abstract_inverted_index.IFNγ.	122
abstract_inverted_index.LAG-3+	89, 157
abstract_inverted_index.PD-1+,	86, 156, 277
abstract_inverted_index.PD-1Hi	248
abstract_inverted_index.PD-1Lo	250
abstract_inverted_index.PD-L1,	107
abstract_inverted_index.across	93
abstract_inverted_index.cells,	21
abstract_inverted_index.design	9
abstract_inverted_index.differ	98
abstract_inverted_index.images	40, 61, 127
abstract_inverted_index.impact	150
abstract_inverted_index.levels	82
abstract_inverted_index.study.	12
abstract_inverted_index.tables	4
abstract_inverted_index.tumors	180
abstract_inverted_index.CTLA4+,	279
abstract_inverted_index.LAG-3+,	278
abstract_inverted_index.Results	266
abstract_inverted_index.TIM-3Hi	259
abstract_inverted_index.TIM-3Lo	261
abstract_inverted_index.counter	221
abstract_inverted_index.density	275
abstract_inverted_index.figures	2
abstract_inverted_index.freshly	113, 178
abstract_inverted_index.samples	94, 131
abstract_inverted_index.DC-LAMP+	26, 281
abstract_inverted_index.analysis	269
abstract_inverted_index.analyzed	182
abstract_inverted_index.clinical	167
abstract_inverted_index.combined	148
abstract_inverted_index.distinct	225
abstract_inverted_index.exposure	119
abstract_inverted_index.isolated	114
abstract_inverted_index.patients	33, 174
abstract_inverted_index.resected	179
abstract_inverted_index.survival	31
abstract_inverted_index.comparing	270
abstract_inverted_index.correlate	28
abstract_inverted_index.cytometry	185
abstract_inverted_index.different	130
abstract_inverted_index.material,	1
abstract_inverted_index.prolonged	30
abstract_inverted_index.staining.	199, 240
abstract_inverted_index.antibodies	195, 206, 234
abstract_inverted_index.biological	169
abstract_inverted_index.cytometry.	210
abstract_inverted_index.expression	111, 271
abstract_inverted_index.prognostic	149
abstract_inverted_index.assessment.	103
abstract_inverted_index.recombinant	121
abstract_inverted_index.represented	246, 257
abstract_inverted_index.Experimental	8
abstract_inverted_index.Supplemental	5, 13, 36, 57, 78, 104, 123, 144, 163, 189, 200, 211, 228, 241, 252, 263
abstract_inverted_index.biostatistic	268
abstract_inverted_index.infiltration	17, 84
abstract_inverted_index.populations.	227
abstract_inverted_index.PD-1Hi/CD8Hi,	134
abstract_inverted_index.PD-1Lo/CD8Lo,	133
abstract_inverted_index.heterogeneous	92
abstract_inverted_index.Representative	39, 60, 126
abstract_inverted_index.differentially	245, 256
abstract_inverted_index.identification	223
abstract_inverted_index.characteristics	170
abstract_inverted_index.immunostaining.	56, 77, 138
abstract_inverted_index.ImmuneHi/TIM-3Hi	289
abstract_inverted_index.ImmuneHi/TIM-3Lo	291
abstract_inverted_index.ImmuneLo/TIM-3Hi	293
abstract_inverted_index.microenvironment	287
abstract_inverted_index.immunofluorescence	239
abstract_inverted_index.<p>Supplemental	0
abstract_inverted_index.PD-1Hi/CD20/DC-LAMPHi	137
abstract_inverted_index.PD-1Lo/CD20/DC-LAMPLo	135
abstract_inverted_index.ImmuneLo/TIM-3Lo.</p>	295
cited_by_percentile_year
countries_distinct_count	0
institutions_distinct_count	21
sustainable_development_goals[0].id	https://metadata.un.org/sdg/3
sustainable_development_goals[0].score	0.5099999904632568
sustainable_development_goals[0].display_name	Good health and well-being
citation_normalized_percentile.value	0.15768045
citation_normalized_percentile.is_in_top_1_percent	False
citation_normalized_percentile.is_in_top_10_percent	False